Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hydroxypropyl-beta-cyclodextrin, also known as Hydroxypropyl-beta-cyclodextrin; THPB; HP-beta-CD; HPbCD; HP-beta-CyD; VTS-270; HPbetaCD; HPbetaCyD, is a drug candidate potentially for the treatment of Niemann-Pick type C diseases. In April 2009, hydroxypropyl-beta-cyclodextrin (HPbCD) was first approved.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | Hydroxypropyl-beta-cyclodextrin, also known as Hydroxypropyl-beta-cyclodextrin; THPB; HP-beta-CD; HPbCD; HP-beta-CyD; VTS-270; HPbetaCD; HPbetaCyD, is a drug candidate potentially for the treatment of Niemann-Pick type C diseases. In April 2009, hydroxypropyl-beta-cyclodextrin (HPbCD) was first approved. |
Synonyms | HP-beta-CyD, VTS-270, HP-beta-CD, Hydroxypropyl-beta-cyclodextri, THPB, HPbCD |
Molecular Weight | 1541.547 |
Formula | C63H112O42 |
CAS No. | 107745-73-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hydroxypropyl-beta-cyclodextrin 107745-73-3 HP-beta-CyD HP-b-CD Hydroxypropyl beta cyclodextrin Hydroxypropyl-b-cyclodextrin Hydroxypropyl-b-cyclodextri Hydroxypropyl-β-cyclodextri VTS-270 HP-b-CyD Hydroxypropylbetacyclodextrin HP-β-CyD HP-beta-CD Hydroxypropyl-beta-cyclodextri VTS270 THPB Hydroxypropyl-β-cyclodextrin HP-β-CD HPbCD VTS 270 inhibitor inhibit